Underweight ORCL: trim 25-30% pre-FOMC, $120/3-month puts, reject adds-on-flush pending confirmed technical recovery
Underweight maintained with magnitude at upper end of calibrated range (25-30% trim). The binding 9/14 reflection template applies: failed breakout + intact RPO floor ($664B contracted revenue, 121% YoY cloud growth) + hostile macro (10Y at 5%, 94% Polymarket odds of zero Fed cuts through 2026) yields measured Underweight, not Sell (RPO provides genuine floor, full liquidation locks losses before structural bull case falsified) and not Hold (empirical record shows 1:1 R/R into binary event leaks alpha under Hold). Reject adds-on-flush as falling knife per 9/03 reflection; all re-engagement requires confirmed technical recovery, not pre-committed breakdown levels.
| Position | Action |
|---|---|
| Current position (sub-2% of book) | Trim 25-30% ahead of FOMC binary catalyst |
| Residual core position after trim (~1.4-1.5% of book) | Defend with single hard stop at $114 on closing basis |
| 75% re-engagement trigger | Close above $155 with >20M volume AND MACD histogram reclaims positive |
| 100% re-engagement trigger | 75% conditions PLUS constructive capex commentary at next earnings (sequential decline OR explicit RPO offset for guide above $60B run-rate) AND stable macro (10Y below 4.75% OR Polymarket no-cut odds below 80%) |
| First add zone $125-130 | Constructive MACD turn AND 10 EMA reclaim on volume confirmation only |
| Second add zone $115-120 | Absorption volume AND bullish RSI divergence AND stabilization at July 2026 low |
| Any FOMC-driven flush without technical confirmation | Reject adds; no preemptive bids on weakness |
Oracle's strong fundamentals—121% cloud growth, $664B contracted RPO, and 30%+ revenue expansion—are being overshadowed by short-term macro fears, creating a rare opportunity to buy a high-quality growth compounder at a cyclical-trough valuation.
| Indicator | Value | Signal |
|---|---|---|
| 10 EMA | 149.52 | bearish |
| 50 SMA | 140.67 | bearish |
| 200 SMA | 166.28 | bearish |
| RSI (14) | 43.00 | neutral |
| MACD Line | 1.33 | bearish |
| MACD Signal Line | 2.42 | bearish |
| MACD Histogram | -1.09 | bearish |
| Bollinger Upper Band | 162.03 | neutral |
| Bollinger Middle Band (20 SMA) | 148.78 | neutral |
| Bollinger Lower Band | 135.52 | neutral |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Close above $155 with >20M volume AND MACD histogram reclaims positive
Then: Re-engage 75% of trimmed size
↩ rebuts: “5-day losing streak”
EV: +40-60% to $185-200 on 12-month horizon · concedes: Debt costs are higher than 18 months ago (though cloud contracts are also priced at premium rates); Fed hiking is a real short-term headwind for long-duration names; 54% drawdown reflects legitimate market concerns about rate environment; Short-term price action has been negative
Oracle's massive capital expenditure program is an unsustainable capital treadmill, not a moat—funding $28.5B quarterly CapEx with $19.9B equity issuance while burning –$5.4B in free cash flow represents a structural cash destruction problem that makes this a SELL.
EV: $95-110 (12-month downside scenario: re-test and break of July 2026 low at $114.99) · concedes: OCI's 121% growth is real and infrastructure is being deployed; Oracle has investment-grade credit rating currently; The $664B RPO backlog is contracted revenue (though requires massive capex to fulfill); Operating cash flow of $23.1B is currently strong (but fully consumed by CapEx)
→ vs conservative: The SELL thesis has a critical flaw: a stock down 54% with PEG of 0.85, forward P/E under 13, and 30% revenue growth does not warrant capitulation. The $664 billion backlog is contracted and legally binding, not 'marketing fluff.' Cloud infrastructure growth of 121% YoY proves conversion is happening. The capex argument is 'overcooked' — this is the hyperscaler playbook, not a debt problem.
→ vs neutral: The HOLD is not passive — protective puts at 130-135 for the 115 zone is hedged long exposure positioned before three known catalysts (FOMC, earnings, 10-year yield direction). Waiting for confirmation means the entry will be gone; by the time evidence clears, ORCL will not be at 140 with these metrics. The analyst should add on flushes toward 125-130 rather than wait on sidelines.
| VWMA (20-day) | 152.38 | bearish |
| ATR (14) | 7.66 | neutral |
Support: 135.52 · 114.99 | Resistance: 148.78 · 149.52 · 162.03 · 166.28
Bearish across all timeframes with price sitting on critical 50 SMA support at $140.67 and pressing lower Bollinger Band at $135.52; MACD histogram flipped sharply negative (-1.09) from +1.61 in just four sessions, confirming momentum deterioration; a breakdown below $135.52 targets the July swing low at $114.99. Trading recommendation is SELL for tactical traders and existing holders; long-term investors should hold only if cost basis is below $120 and accumulate at $115 or below.
Market Cap
$404.27B
Beta
1.732
Implied Current Price
~$140.34
52-Week High
$329.50
52-Week Low
$114.50
50-Day Average
$140.77
200-Day Average
$167.37
P/E (TTM)
21.96
Forward P/E
12.77
PEG Ratio
0.85
Price/Book
10.76
Dividend Yield
1.38%
Revenue (TTM)
$71.78B
Gross Profit
$45.91B
Gross Margin
64.0%
EBITDA
$34.43B
EBITDA Margin
48.0%
Operating Income (TTM)
~$25.58B
Operating Margin
35.6%
Net Income
$18.74B
Net Margin
26.4%
ROE
41.19%
ROA
6.36%
Revenue YoY Growth
~+30%
Forward EPS Growth
+72%
Q1 (Aug 2025) Revenue
$14.93B
Q1 (Aug 2025) Diluted EPS
$1.01
Q2 (Nov 2025) Revenue
$16.06B
Q2 (Nov 2025) Diluted EPS
$2.10
Q3 (Feb 2026) Revenue
$17.19B
Q3 (Feb 2026) Diluted EPS
$1.27
Q4 (May 2026) Revenue
$19.18B
Q4 (May 2026) Diluted EPS
$1.45
Q5 (Aug 2026) Revenue
$19.35B
Q5 (Aug 2026) Diluted EPS
$1.56
Sequential Revenue Growth
+29.6%
Total Assets
$303.26B
Total Liabilities
$236.06B
Stockholders' Equity
$66.77B
Long-Term Debt
$117.71B
Capital Lease Obligations (LT)
$30.59B
Total Debt
$155.93B
Cash & Equivalents
$36.37B
Net Debt
$88.97B
Debt / Equity
251.7%
Current Ratio
1.17
Net PPE
$161.81B
Net PPE YoY Change
+204%
Operating Cash Flow
$23.10B
Capital Expenditure
-$28.50B
Free Cash Flow
-$5.40B
Dividends Paid
-$1.57B
Debt Repayments
-$5.03B
Stock Issuance
+$19.91B
End Cash Position
$38.93B
Preferred Stock Issued
$4.95B
Strengths
Concerns
Oracle presents a compelling value case on a forward basis (Forward P/E 12.77, PEG 0.85) with 30% YoY revenue growth accelerating to $19.35B quarterly and world-class profitability metrics (64% gross margin, 41% ROE), but the aggressive infrastructure build-out (CapEx of $28.5B quarterly, Net PPE tripling to $161.8B) has created significant leverage (Net Debt $89B, D/E 251.7%) and negative free cash flow (-$5.4B), necessitating a cautious HOLD until capital intensity normalizes and FCF turns durably positive.
Macro: Rates-driven reflation shock: 10Y Treasury at highest since 2007 (briefly >5%), oil sticky above $100/barrel (intraday $105 print), gold and silver selling off ahead of Fed (hawkish signal), Dow/S&P/Nasdaq lower on the week, chip stocks particularly weak amid AI-warning tape. Polymarket implies 88% probability of +25 bps at Sept 16 FOMC and 94% probability of zero cuts in all of 2026. Recession probability at 16% (up 8 pp in one week). Hostile backdrop for long-duration growth equities where ORCL sits as multi-year capex-heavy AI-cloud compounder. Note: FRED macro-indicator tool returned DATA_UNAVAILABLE; all macro data derived from news flow and prediction markets rather than underlying economic series.